JMD Conference & Exhibition
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orlow, I.
Right arrow Articles by Berwick, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orlow, I.
Right arrow Articles by Berwick, M.
JMD 2001, Vol. 3, No. 4
Copyright © 2001 American Society for Investigative Pathology & Association for Molecular Pathology

Validation of Denaturing High Performance Liquid Chromatography as a Rapid Detection Method for the Identification of Human INK4A Gene Mutations

Irene Orlow, Pampa Roy, Allison Barz, Rebecca Canchola, Yan Song and Marianne Berwick

From the Molecular Epidemiology Laboratory, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York

The incidence of melanoma is increasing rapidly in western countries. Genetic predisposition in familial and in some sporadic melanomas has been associated with the presence of INK4A gene mutations. To better define the risk for developing sporadic melanoma based on genetic and environmental interactions, large groups of cases need to be studied. Mutational analysis of genes lacking hot spots for sequence variations is time consuming and expensive. In this study we present the application of denaturing high performance liquid chromatography (DHPLC) for screening of mutations. Exons 1{alpha}, 2, and 3 were amplified from 129 samples and 13 known mutants, yielding 347 products that were examined at different temperatures. Forty-two of these amplicons showed a distinct non-wild-type profile on the chromatogram. Independent sequencing analysis confirmed 16 different nucleotide variations in Leu32Pro; Ile49Thr; 88 del G; Gln50Arg; Arg24Pro; Met53Ile; Met53Thr; Arg58stop; Pro81Leu; Asp84Ala; Arg80stop; Gly101Trp; Val106Val; Ala148Thr; and in positions (-2) in intron 1 (C -> T); and in the 3' UTR, nucleotide 500 (C -> G). No false negatives or false positives were obtained by DHPLC in samples with mutations or polymorphisms. We conclude that the DHPLC is a fast, sensitive, cost-efficient, and reliable method for the scanning of INK4A somatic or germline mutations and polymorphisms of large number of samples.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Berwick, I. Orlow, A. J. Hummer, B. K. Armstrong, A. Kricker, L. D. Marrett, R. C. Millikan, S. B. Gruber, H. Anton-Culver, R. Zanetti, et al.
The Prevalence of CDKN2A Germ-Line Mutations and Relative Risk for Cutaneous Malignant Melanoma: An International Population-Based Study.
Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1520 - 1525.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
C. B. Begg, I. Orlow, A. J. Hummer, B. K. Armstrong, A. Kricker, L. D. Marrett, R. C. Millikan, S. B. Gruber, H. Anton-Culver, R. Zanetti, et al.
Lifetime Risk of Melanoma in CDKN2A Mutation Carriers in a Population-Based Sample
J Natl Cancer Inst, October 19, 2005; 97(20): 1507 - 1515.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Ahsan and A. G. Rundle
Measures of genotype versus gene products: promise and pitfalls in cancer prevention
Carcinogenesis, September 1, 2003; 24(9): 1429 - 1434.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
O. A. Bodamer, D. Bercovich, M. Schlabach, C. Ballantyne, D. Zoch, and A. L. Beaudet
Use of Denaturing HPLC to Provide Efficient Detection of Mutations Causing Familial Hypercholesterolemia
Clin. Chem., November 1, 2002; 48(11): 1913 - 1918.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society for Investigative Pathology and the Association for Molecular Pathology.